Evidence map›Paper›PMID 35945010›Full record

ArticleInternal medicine (Tokyo, Japan)2023

Pulmonary Langerhans Cell Histiocytosis That Progressed from a Single-system to a Multisystem Form despite Smoking Cessation.

Hiroshi Ishimoto, Noriho Sakamoto, Mutsumi Ozasa, Takeharu Katoh, Hidehiro Itonaga, Makoto Wataya, Daisuke Takao, Atsuko Hara, Takashi Kido, Hiroyuki Yamaguchi and 5 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Hiroshi IshimotoDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Noriho SakamotoDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Mutsumi OzasaDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Takeharu KatohDepartment of Hematology, Nagasaki University Hospital, Japan.
Hidehiro ItonagaDepartment of Hematology, Nagasaki University Hospital, Japan.
Makoto WatayaDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Daisuke TakaoDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Atsuko HaraDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Takashi KidoDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Hiroyuki YamaguchiDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Kazuko YamamotoDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Yasushi ObaseDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Yuji IshimatsuDepartment of Nursing, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Yasushi MiyazakiDepartment of Hematology, Nagasaki University Hospital, Japan.
Hiroshi MukaeDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Nagasaki University · JPNagasaki University Hospital · JPHiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 36-year-old Japanese man presented with cavities and nodular shadows in the lower lobes of his lungs and osteolytic lesions in the thoracic spine. He was diagnosed with multisystem Langerhans cell histiocytosis (LCH). Three years earlier, he had been noted to have small cavities and granular lesions noted in the upper lobes of his lungs, which later improved with smoking cessation. It was likely that his single-system pulmonary LCH (PLCH) progressed to multisystem LCH despite smoking cessation. Relapse or progression may occur in cases where PLCH lesions improve after smoking cessation. Thus, close follow-up is vital.

Indexed as

Histiocytosis, Langerhans-CellSmoking CessationAdultHumansLungMaleRecurrenceTomography, X-Ray Computedcase reportcavitary lesionnodular changepulmonary Langerhans cell histiocytosissmoking cessation

Identifiers

PMID35945010
PMCPMC10076126
OpenAlexW4291633026

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.